COL1A1 and hepatocellular carcinoma: Taken together, our data suggest that treatment with losartan might attenuate the strong cell-cell adhesion by suppression of COL1A1 synthesis in tightly compacted HCC spheroids, thereby facilitating the robust therapeutic activity of combined losartan and anticancer therapies in human liver carcinomas.